Skip to main content
Top
Published in: Clinical Rheumatology 2/2020

01-02-2020 | Osteoarthrosis | Original Article

Alterations in peripheral T cell and B cell subsets in patients with osteoarthritis

Authors: Wanshou Zhu, Xi Zhang, Yutong Jiang, Xiaolian Liu, Linyan Huang, QiuJing Wei, Yefei Huang, Weilong Wu, Jieruo Gu

Published in: Clinical Rheumatology | Issue 2/2020

Login to get access

Abstract

Objectives

Our study objective was to explore whether abnormalities in the subtypes of T cells and B cells were present in peripheral blood of patients with osteoarthritis (OA) and healthy controls (HCs).

Method

Demographic and clinical variables and blood were collected. OA severity was measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire. Flow cytometry was used to establish the frequencies of lineage subsets. Monoclonal antibodies against 21 surface markers were used to distinguish and evaluate T cells’ and B cells’ subpopulation. The proportion of each subset was compared and correlations between age, immune cells, and clinical data were analyzed.

Results

A total of 30 OA patients (male/female = 9/21) and 45 HCs (male/female = 14/31) were included. Median WOMAC pain was 3.0 (2.0). There was no difference in the proportion of T cells, CD8+ T cells, and B cells (p > 0.05). The proportion of CD4+ T cells was higher in OA groups, together with an increased CD4 to CD8 ratio (p = 0.016). CD8+CD45RA+ T cells were reduced after adjustment for age, while CD8+CD45RA− T cells were elevated in OA (p < 0.05). CD4+CD45RA−CCR7+ T cells and CD4+CD45RA−CCR7− T cells were increased (p < 0.004). The proportion of T helper (Th) 17 and T follicular helper (Tfh) 2 cells was higher, but cytotoxic T (Tc) 17 cells were fewer in OA (p < 0.05). CD3−CD19+IgD−IgM−CD27+CD38+ B cells were decreased in OA (p ≤ 0.001). The WOMAC pain score correlated with CD3+CD4+CXCR5−PD-1+ T cells positively (B = 0.404, p = 0.027). CD3−CD19+CD27−IgD+ cells correlated negatively with erythrocyte sedimentation rate (ESR) (B = −0.550, p = 0.005).

Conclusions

The T cell and B cell profiles were proved to have alteration suggesting that acquired immune system may play a substantial role in the pathogenesis of OA.
Key Points
• The T cell and B cell profiles were proved to have alteration suggesting that acquired immune system may play a substantial role in the pathogenesis of OA.
• The WOMAC pain score correlated with CD3+CD4+CXCR5−PD-1+ T cells and T helper 17 cells positively.
• Memory T cells were increased in OA patients, suggesting they could play an important role in OA.
Literature
1.
go back to reference Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73:1323–1330CrossRef Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73:1323–1330CrossRef
2.
go back to reference Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635–646CrossRef Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635–646CrossRef
3.
go back to reference Pawelec G (2012) Hallmarks of human “immunosenescence”: adaptation or dysregulation? Immun Ageing 9:15CrossRef Pawelec G (2012) Hallmarks of human “immunosenescence”: adaptation or dysregulation? Immun Ageing 9:15CrossRef
4.
go back to reference Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil 21:16–21CrossRef Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil 21:16–21CrossRef
5.
go back to reference Huber-Lang M, Kovtun A, Ignatius A (2013) The role of complement in trauma and fracture healing. Semin Immunol 25:73–78CrossRef Huber-Lang M, Kovtun A, Ignatius A (2013) The role of complement in trauma and fracture healing. Semin Immunol 25:73–78CrossRef
6.
go back to reference Geginat J, Paroni M, Facciotti F, Gruarin P, Kastirr I, Caprioli F, Pagani M, Abrignani S (2013) The CD4-centered universe of human T cell subsets. Semin Immunol 25:252–262CrossRef Geginat J, Paroni M, Facciotti F, Gruarin P, Kastirr I, Caprioli F, Pagani M, Abrignani S (2013) The CD4-centered universe of human T cell subsets. Semin Immunol 25:252–262CrossRef
7.
go back to reference de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ et al (2012) Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthr Cartil 20:1484–1499CrossRef de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ et al (2012) Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthr Cartil 20:1484–1499CrossRef
9.
go back to reference Crotty S (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621–663CrossRef Crotty S (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621–663CrossRef
10.
go back to reference Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh SK, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H (2011) Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108–121CrossRef Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh SK, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H (2011) Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108–121CrossRef
11.
go back to reference Shan Y, Qi C, Liu Y, Gao H, Zhao D, Jiang Y (2017) Increased frequency of peripheral blood follicular helper T cells and elevated serum IL21 levels in patients with knee osteoarthritis. Mol Med Rep 15:1095–1102CrossRef Shan Y, Qi C, Liu Y, Gao H, Zhao D, Jiang Y (2017) Increased frequency of peripheral blood follicular helper T cells and elevated serum IL21 levels in patients with knee osteoarthritis. Mol Med Rep 15:1095–1102CrossRef
12.
go back to reference Da RR, Qin Y, Baeten D, Zhang Y (2007) B cell clonal expansion and somatic hypermutation of Ig variable heavy chain genes in the synovial membrane of patients with osteoarthritis. J Immunol 178:557–565CrossRef Da RR, Qin Y, Baeten D, Zhang Y (2007) B cell clonal expansion and somatic hypermutation of Ig variable heavy chain genes in the synovial membrane of patients with osteoarthritis. J Immunol 178:557–565CrossRef
13.
go back to reference Du H, Masuko-Hongo K, Nakamura H et al (2005) The prevalence of autoantibodies against cartilage intermediate layer protein, YKL-39, osteopontin, and cyclic citrullinated peptide in patients with early-stage knee osteoarthritis: evidence of a variety of autoimmune processes. Rheumatol Int 26:35–41CrossRef Du H, Masuko-Hongo K, Nakamura H et al (2005) The prevalence of autoantibodies against cartilage intermediate layer protein, YKL-39, osteopontin, and cyclic citrullinated peptide in patients with early-stage knee osteoarthritis: evidence of a variety of autoimmune processes. Rheumatol Int 26:35–41CrossRef
14.
go back to reference Echtermeyer F, Bertrand J, Dreier R, Meinecke I, Neugebauer K, Fuerst M, Lee YJ, Song YW, Herzog C, Theilmeier G, Pap T (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 15:1072–1076CrossRef Echtermeyer F, Bertrand J, Dreier R, Meinecke I, Neugebauer K, Fuerst M, Lee YJ, Song YW, Herzog C, Theilmeier G, Pap T (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 15:1072–1076CrossRef
15.
go back to reference Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed
16.
go back to reference Kondo T, Takata H, Takiguchi M (2007) Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells. Eur J Immunol 37:54–65CrossRef Kondo T, Takata H, Takiguchi M (2007) Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells. Eur J Immunol 37:54–65CrossRef
17.
go back to reference Hermiston ML, Xu Z, Weiss A (2003) CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21:107–137CrossRef Hermiston ML, Xu Z, Weiss A (2003) CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21:107–137CrossRef
18.
go back to reference Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, Easterbrook P, Grey P, Smith D, McMichael AJ, Cooper DA, Rowland-Jones SL, Kelleher AD (2002) Characterization of CD4(+) CTLs ex vivo. J Immunol 168:5954–5958CrossRef Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, Easterbrook P, Grey P, Smith D, McMichael AJ, Cooper DA, Rowland-Jones SL, Kelleher AD (2002) Characterization of CD4(+) CTLs ex vivo. J Immunol 168:5954–5958CrossRef
19.
go back to reference Haynes MK, Hume EL, Smith JB (2002) Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids. Clin Immunol 105:315–325CrossRef Haynes MK, Hume EL, Smith JB (2002) Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids. Clin Immunol 105:315–325CrossRef
20.
go back to reference Ezawa K, Yamamura M, Matsui H, Ota Z, Makino H (1997) Comparative analysis of CD45RA- and CD45RO-positive CD4+T cells in peripheral blood, synovial fluid, and synovial tissue in patients with rheumatoid arthritis and osteoarthritis. Acta Med Okayama 51:25–31PubMed Ezawa K, Yamamura M, Matsui H, Ota Z, Makino H (1997) Comparative analysis of CD45RA- and CD45RO-positive CD4+T cells in peripheral blood, synovial fluid, and synovial tissue in patients with rheumatoid arthritis and osteoarthritis. Acta Med Okayama 51:25–31PubMed
21.
go back to reference Ponchel F, Burska AN, Hensor EM et al (2015) Changes in peripheral blood immune cell composition in osteoarthritis. Osteoarthr Cartil 23:1870–1878CrossRef Ponchel F, Burska AN, Hensor EM et al (2015) Changes in peripheral blood immune cell composition in osteoarthritis. Osteoarthr Cartil 23:1870–1878CrossRef
22.
go back to reference Sallusto F, Lenig D, Forster R et al (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712CrossRef Sallusto F, Lenig D, Forster R et al (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712CrossRef
23.
go back to reference Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745–763CrossRef Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745–763CrossRef
24.
go back to reference Miossec P, Kolls JK (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11:763–776CrossRef Miossec P, Kolls JK (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11:763–776CrossRef
25.
go back to reference Zhang L, Li JM, Liu XG, Ma DX, Hu NW, Li YG, Li W, Hu Y, Yu S, Qu X, Yang MX, Feng AL, Wang GH (2011) Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 31:606–614CrossRef Zhang L, Li JM, Liu XG, Ma DX, Hu NW, Li YG, Li W, Hu Y, Yu S, Qu X, Yang MX, Feng AL, Wang GH (2011) Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 31:606–614CrossRef
26.
go back to reference Qi C, Shan Y, Wang J, Ding F, Zhao D, Yang T, Jiang Y (2016) Circulating T helper 9 cells and increased serum interleukin-9 levels in patients with knee osteoarthritis. Clin Exp Pharmacol Physiol 43:528–534CrossRef Qi C, Shan Y, Wang J, Ding F, Zhao D, Yang T, Jiang Y (2016) Circulating T helper 9 cells and increased serum interleukin-9 levels in patients with knee osteoarthritis. Clin Exp Pharmacol Physiol 43:528–534CrossRef
27.
go back to reference Kim J, Kang S, Kim J, Kwon G, Koo S (2013) Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis. Ann Lab Med 33:52–59CrossRef Kim J, Kang S, Kim J, Kwon G, Koo S (2013) Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis. Ann Lab Med 33:52–59CrossRef
28.
go back to reference Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, Jiang S, Kuchroo VK, Mathis D, Roncarolo MG, Rudensky A, Sakaguchi S, Shevach EM, Vignali DAA, Ziegler SF (2013) Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 14:307–308CrossRef Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, Jiang S, Kuchroo VK, Mathis D, Roncarolo MG, Rudensky A, Sakaguchi S, Shevach EM, Vignali DAA, Ziegler SF (2013) Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 14:307–308CrossRef
29.
go back to reference Wilkinson M, Rosser EC (2019) B cells as a therapeutic target in paediatric rheumatic disease. Front Immunol 10:214CrossRef Wilkinson M, Rosser EC (2019) B cells as a therapeutic target in paediatric rheumatic disease. Front Immunol 10:214CrossRef
30.
go back to reference Shiokawa S, Matsumoto N, Nishimura J (2001) Clonal analysis of B cells in the osteoarthritis synovium. Ann Rheum Dis 60:802–805CrossRef Shiokawa S, Matsumoto N, Nishimura J (2001) Clonal analysis of B cells in the osteoarthritis synovium. Ann Rheum Dis 60:802–805CrossRef
Metadata
Title
Alterations in peripheral T cell and B cell subsets in patients with osteoarthritis
Authors
Wanshou Zhu
Xi Zhang
Yutong Jiang
Xiaolian Liu
Linyan Huang
QiuJing Wei
Yefei Huang
Weilong Wu
Jieruo Gu
Publication date
01-02-2020
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04768-y

Other articles of this Issue 2/2020

Clinical Rheumatology 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.